Cancerify Logo
Log inSign up
Back to clinical trials
RecruitingObservational

Molecular Fingerprinting of Lung Cancer

NCT ID: NCT00897117Sponsor: Vanderbilt-Ingram Cancer CenterLast updated: 2025-09-26

Summary

RATIONALE: Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that may occur in RNA and identify biomarkers related to cancer. PURPOSE: This research study is collecting and analyzing lung tissue samples from patients undergoing surgery for non-small cell lung cancer.

Detailed description

OBJECTIVES: * Develop statistical and computational methods for modeling the relationships between multiple variable protein and RNA expression data and clinical endpoints using both supervised and unsupervised classification and pattern recognition approaches. * Determine protein and RNA expression fingerprints on completely resected non-small cell lung cancer without prior chemotherapy. * Correlate protein and RNA expression fingerprints with T-stage and nodal involvement at the time of surgery, and collect outcome data to allow correlation with recurrence (local and/or distant) and survival. OUTLINE: This is a multicenter study. Any excess tissues removed from surgery and would otherwise be discarded (tissues not used for diagnosis and/or treatment decision making) are obtained for this study. Tissue are analyzed for molecular features that predict biologic behavior. Quantitation of RNA, gene expression profiles, and protein expression patterns are assessed by matrix-assisted laser desorption/ionization time of flight mass spectroscopy and microarray analysis. Medical records are reviewed to obtain information about results of tests associated with cancer diagnosis. Further progress in cancer treatment and tumor behavior after surgery are followed via record review.

Arms & interventions

  • Geneticgene expression analysis

    Blood and lung tissue collection

  • Geneticmicroarray analysis

    Blood and lung tissue collection

  • Geneticprotein expression analysis

    Blood and lung tissue collection

  • Otherbiologic sample preservation procedure

    Blood and lung tissue collection

  • Otherlaboratory biomarker analysis

    Blood and lung tissue collection

  • Othermatrix-assisted laser desorption/ionization time of flight mass spectrometry

    Blood and lung tissue collection

Outcome measures

Primary

  • Protein and RNA expression fingerprints from collected samples

    Time frame: after collection of designated samples

Secondary

  • Development of statistical and computational methods to model relationship of data and clinical outcomes

    Time frame: after laboratory gene analysis work is completed

  • Correlation of protein and RNA expression fingerprints with recurrence (local and/or distant) and survival

    Time frame: after collection of designated samples

Eligibility criteria

Sex: AllAge: 18 Years to 120 YearsHealthy volunteers: No
Inclusion criteria * Diagnosis of non-small cell lung cancer * Clinical stage I and II disease * Resectable disease and complete surgical resection planned * Treated on companion studies at Vanderbilt University, the Veterans Administration hospital, St. Thomas, and Vanderbilt-Ingram Cancer Center Affiliate Network * Tumor specimen samples must be available at resection Exclusion criteria * Chemotherapy before surgery * Radiotherapy before surgery

Study locations (3)

Dan Rudy Cancer Center at Saint Thomas Hospital

Nashville, Tennessee, 37205

Completed

Veterans Affairs Medical Center - Nashville

Nashville, Tennessee, 37212

Suspended

Vanderbilt-Ingram Cancer Center

Nashville, Tennessee, 37232-6838

Recruiting
Clinical Trials Office - Vanderbilt-Ingram Cancer Center · Contact
Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer | Cancerify